1 bicyclo 2 2 1 hept 5 en 2 yl 1 phenyl 3 piperidin 1 yl propan 1 ol, alpha 5 norbornen 2 yl alpha phenyl 1 piperidinepropanol, alpha bicyclo 2 2 1 hept 5 en 2 yl alpha phenyl 1 piperidinepropanol							
	
							
							
								
																	
																	
	
								
																	
							
							
																						
								 For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.